Msr Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.20 Cr
- Paid Up Capital ₹ 1.10 Cr
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.70 Cr
- Revenue Growth 1116.37%
- Profit Growth 221.71%
- Ebitda -50.58%
- Net Worth 165.05%
- Total Assets -1.59%
About Msr Life Sciences
Msr Life Sciences Private Limited (MLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 April 2016 (Eight years and ten months 0 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.20 Cr and a paid-up capital of Rs 1.10 Cr.
The company has closed loans amounting to ₹2.70 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Padmaja Dantu and Koti Dantu serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01409TG2016PTC109177
- Company No.
109177
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Apr 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Msr Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Padmaja Dantu  | Director | 19-Nov-2016 | Current |
| Koti Dantu | Director | 23-Apr-2016 | Current |
Financial Performance of Msr Life Sciences.
Msr Life Sciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 1116.37% increase. The company also saw a substantial improvement in profitability, with a 221.71% increase in profit. The company's net worth Soared by an impressive increase of 165.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Msr Life Sciences?
In 2021, Msr Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹2.70 Cr
Charges Breakdown by Lending Institutions
- Canara Bank : 2.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2016 | Canara Bank | ₹2.70 Cr | Satisfied |
How Many Employees Work at Msr Life Sciences?
Unlock and access historical data on people associated with Msr Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Msr Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Msr Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
